Evidence Corner: Evidence-based Care for Malignant Wounds.

Area of Science:

• Oncology
• Wound Care
• Palliative Care

Background:

• Malignant fungating wounds affect 5-10% of cancer patients, arising from tumor cell infiltration of the skin.
• Current treatment guidelines for malignant wounds (MW) often lack robust randomized clinical trial (RCT) evidence.
• Patients and caregivers identify pain, infection, and odor as primary challenges in managing MW distress.

Purpose of the Study:

• To review current best evidence for managing malignant wounds (MW).
• To inform clinical decisions for alleviating patient distress associated with MW.
• To highlight the limited but emerging RCT evidence in MW care.

Main Methods:

• Systematic review of recent randomized clinical trials (RCTs) on malignant wound management.
• Analysis of evidence addressing physical and psychosocial needs of patients with MW.
• Inclusion of findings from a recent Cochrane review on MW interventions.

Main Results:

• Evidence for local wound care interventions in MW remains insufficient.
• Two recent RCTs provide "current best evidence" for MW management.
• Focus on alleviating patient distress, including pain, infection, and odor, is crucial.

Conclusions:

• Despite limited RCT evidence, recent trials offer guidance for MW symptom management.
• Addressing physical and psychosocial needs is paramount for patients with MW.
• Further research is needed to establish definitive evidence-based guidelines for MW care.